Martin C. Mihm, Jr. MD – Brigham & Women’s Hospital
Beth E. Ruben MD – Palo Alto Medical Foundation
David E. Elder MD – Univ. of Pennsylvania
Tammie C. Ferringer MD – Geisinger Medical Labs

Victor G. Prieto MD – MD Anderson Cancer Center
Whitney High MD – Univ. of Colorado
Michael T. Tetzlaff MD – MD Anderson Cancer Center
Konstantinos Linos MD – Dartmouth Univ.

Dr. Martin Mihm Jr. is the Director of the Melanoma Program in Dermatology at the Brigham and Women’s Hospital and Associate Director Dana-Farber and Brigham and Women’s Cancer Center. Dr. Mihm holds now five adjunct professorships at different schools in the United States. He also was a co-founder of the Rare Tumor Institute of the WHO in Milan, Italy and acted as external coordinator for five years. He is currently co-director of the EORTC melanoma pathology program. He has written over four hundred articles and authored and co-authored twelve books. He graduated from the University of Pittsburgh Medical Center in 1961 and specialized in Internal Medicine, Dermatology, Pathology, and Dermatopathology. He started residency in dermatology at the Massachusetts General Hospital (MGH) in 1964 and after completing pathology residency joined the staff in 1973. He is board certified in Dermatology, Pathology, and Dermatopathology. His research interests have principally been related to malignant melanoma, the study of delayed hypersensitivity reactions in animals and humans, and more recently has begun to investigate the pathogenesis of vascular anomalies. While excelling, as an academician and clinician, he has also built a busy consultation service. As the director of the Mihm Cutaneous Pathology Consultative Service (MCPCS), at the Brigham and Women’s Hospital, his expanse knowledge and unrivaled expertise in the fields of pigmented lesions, melanoma, non-melanoma skin cancers, and inflammatory disorders has made his opinion one that is highly sought after. To date, he has consulted on more than 300,000 cases, nationally and worldwide. He continues to offer accurate diagnosis, prognosis, and treatment recommendations on routine and challenging cases in Dermatology/Dermatopathology.

Dr. Beth S. Ruben is Professor of Dermatology and Pathology at the University of California, San Francisco, and now chief of dermatopathology at Palo Alto Medical Foundation. Dr. Ruben graduated from Stanford University School of Medicine, and completed a medical and surgical internship at California Pacific Medical Center, and Dermatology Residency at UC Davis. She then undertook Dermatopathology Fellowship training at UCSF. During her 11 years on full time faculty at UCSF she practiced in one of the largest academic dermatopathology practices in the United States, with over 100,000 accessions reported annually, including a significant consultation practice. She also served as Director of the Dermatopathology Fellowship Program. She is a frequently invited speaker at national and international dermatology and dermatopathology meetings. Her special interests in both presentations and publications include nail pathology, inpatient (hospital) dermatopathology, drug eruptions, and pathology of melanocytic neoplasms, including those in the nail unit. She is a founding member of the International Melanonychia Study group, and Past President of the Council for Nail Disorders. She is on the editorial board of the new journal Skin Appendage Disorders, and the Journal of Cutaneous Pathology. She is the author of several chapters on nail disease in dermatopathology textbooks, as well as in the nail disease textbooks (Scher and Daniel and Baran, et. al).

Dr. David Elder is Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. He trained in New Zealand at the University of Otago and with Dr. Vincent McGovern of the Sydney Melanoma Unit in Australia. He then moved to Philadelphia, initially with Dr Wallace H Clark Jr. at Temple University and then at the University of Pennsylvania. Dr. Elder was Vice Chair for Anatomic Pathology in the Department of Pathology and Laboratory Medicine from 1999 through 2011, and was a founding member of the Penn Melanoma and Pigmented Lesion Study Group in 1978, and the Melanoma Program of the Abramson Cancer Institute at the Perelman School of Medicine at the University of Pennsylvania. Dr. Elder is the author of more than 200 peer-reviewed research publications and reviews. In addition, he has authored or edited several textbooks, including the 3rd and 4th series US Armed Forces Institute of Pathology Fascicles on Melanocytic Tumors of the Skin, and he has also been Editor in Chief for the last four editions of Lever’s Histopathology of the Skin, a book that has been continuously published since 1948 and is a leading textbook in the field of dermatopathology. Another publication is the Atlas and Synopsis of Lever’s Histopathology of the Skin, now in its third edition, which presents a unified pattern classification system for inflammatory and neoplastic skin diseases.

Dr. Whitney High is a board-certified dermatologist and dermatopathologist at the University of Colorado in Denver. He received his Bachelor’s and Master’s degree in Chemical Engineering from the Colorado School of Mines in Golden, Colorado. After spending some time in industry, he returned to medical school to earn his degree from Mayo Clinic School of Medicine in Rochester, Minnesota. Dr. High completed his internship at P/SL Medical Center in Denver, Colorado, followed by a dermatology residency at the University of Texas, Southwestern Medical Center, in Dallas, Texas, where he served as a Chief Resident. A dermatopathology fellowship was completed at the University of Colorado, where he has remained on faculty. Dr. High has also earned a diploma in Tropical Medicine & Hygiene from the Gorgas Institute in Lima, Peru. In his spare time, he attended law school at the University of Denver Sturm School of Law, earning his Juris Doctorate, in addition to his medical degree and advanced engineering degree. Dr. High has published a large number of papers in peer-reviewed journals, he has authored numerous chapters in dermatology and dermatopathology textbooks, and he has co-authored three textbooks with other leaders in his field. He lectures nationally and internationally on a variety of topics in dermatology and dermatopathology. Dr. High’s collaborative research laboratory was first to discover gadolinium in the tissue of patients with nephrogenic systemic fibrosis.

Dr. Tammie Ferringer is the section head for Geisinger Medical Laboratory’s dermatopathology subspecialty section. She is also an Associate in the Department of Dermatology at Geisinger Medical Center and serves as the director of the Dermatopathology Fellowship Program. She earned her MD at Medical College of Pennsylvania and completed her dermatology residency at Geisinger Medical Center in Danville, Pennsylvania. After completing her dermatopathology fellowship at Medical University of South Carolina in 2004, Dr. Ferringer returned to Geisinger Medical Center to fulfil her passion to teach and mentor. She currently sees patients 2 half-days per week, and devotes the remainder of her time to academic endeavors, administration, and dermatopathology. Her current literary contributions include over 50 journal articles or textbook chapters, co-editor of a dermatopathology textbook, and co-author of an online and mobile dermatopathology application with Dr. Dirk Elston.

Dr. Victor Prieto is the chairman at MD Anderson Cancer Center. He is also a professor of dermatopathology and one of the worlds foremost experts in melanocytic dermatopathology. He has also authored over 300 peer-reviewed publications and is the author of numerous Dermatopathology textbooks. Victor G. Prieto, M.D., Ph.D., received his BA degree from the International School Lope de Vega, Benidorm, Spain; his M.D. from the University of Alicante, Spain; and his Ph.D. from the University of Barcelona, Spain. He took residency training in Pathology at the Hospital del Mar in Barcelona and at the New York Hospital-Cornell Medical Center. He took Fellowship training in Oncologic Pathology, at the Memorial Sloan Kettering Cancer Center and in Dermatopathology at the New York Hospital-Cornell Medical Center.

Dr. Michael Tetzlaff is an Associate Professor at The University of Texas MD Anderson Cancer Center in Houston Texas in the Departments of Pathology (Section of Dermatopathology) and Translational and Molecular Pathology. He is the Executive Officer for the Translational Research Program for The Alliance for Clinical Trials and directs the Imunohistochemistry C ore Laboratory for the Melanoma Moonshot Program at MD Anderson. Dr. Tetzlaff earned his medical degree from the University of Texas at Austin. He completed his residency in Anatomic Pathology in The Department of Pathology with fellowship in the Department of Dermatology at The Hospital of the University of Pennsylvania. Following his training, Dr. Tetzlaff began his academic career at MD Anderson. He serves on the Editorial Boards of Human Pathology, American Journal of Clinical Pathology and Applied Immunohistochemistry &Molecular Morphology. He is an author of over 100 published peer-reviewed manuscripts.

Dr. Konstantinos Linos – is a dermatopathologist at Dartmouth-Hitchcock Medical Center / Geisel School of Medicine. He has completed fellowships in dermatopathology, surgical pathology, and soft tissue pathology from Memorial Sloan Kettering Cancer Center, Indiana University, and Emory University, respectively. He is the director of bone and soft tissue pathology at the Dartmouth-Hitchcock school of medicine. Dr. Linos has coauthored Diagnostic Pathology: Vascular and also serves as the course director for the Southeastern Pathology Conference. PROGRAM DIRECTOR